TCTR20160316001已完成未知
Efficacy and safety of reduced-dose intravitreal ganciclovir for treatment of cytomegalovirus retinitis (CMVR)
Siriraj Development Research Fund (managed by Routine to Research:R2R)0 个研究点目标入组 60 人开始时间: 2016年3月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 0 N/A (No limit)（—）
- 性别
- All
入选标准
- •Patients with cytomegalovirus retinitis
排除标准
- •patients with concomitant retinal inflammation
- •patients who previously treated with ganciclovir
研究者
相似试验
已完成
不适用
Evaluation of the efficacy and safety of intravitreal injection of ranibizumab every other month for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000005691Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy and safety of intravitreal bimonthly injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000010312Department of Ophthalmology, Shiga University of Medical Science40
已完成
2 期
Study of brachytherapy in rectal cancerRectal cancer.Rectal and anal canal neoplasmsC20, C21.1IRCT201501059979N2Vice chancellor for research,, Shiraz University of Medical Sciences30
招募中
4 期
A clinical trial to study the efficacy and safety of low dose versus standard dose emicizumab prophylaxis in haemophilia A patients.CTRI/2024/01/061593Department of Health Research, India
尚未招募
不适用
Evaluation of efficacy of dose-adjusted intravenous busulfan in allogeneic hematopoietic stem cell transplantation by analyzing busulfan concentration in dried blood spot method.Hematological malignancyJPRN-UMIN000019501Kurashiki Central Hospital50